Unknown

Dataset Information

0

Efficacy of Cell-Based Therapies for Traumatic Brain Injuries.


ABSTRACT: Traumatic brain injuries (TBIs) are a leading cause of death and disability. Additionally, growing evidence suggests a link between TBI-induced neuroinflammation and neurodegenerative disorders. Treatments for TBI patients are limited, largely focused on rehabilitation therapy, and ultimately, fail to provide long-term neuroprotective or neurorestorative benefits. Because of the prevalence of TBI and lack of viable treatments, new therapies are needed which can promote neurological recovery. Cell-based treatments are a promising avenue because of their potential to provide multiple therapeutic benefits. Cell-based therapies can promote neuroprotection via modulation of inflammation and promote neurorestoration via induction of angiogenesis and neurogenesis. Neural stem/progenitor cell transplantations have been investigated in preclinical TBI models for their ability to directly contribute to neuroregeneration, form neural-like cells, and improve recovery. Mesenchymal stem cells (MSCs) have been investigated in clinical trials through multiple different routes of administration. Intravenous administration of MSCs appears most promising, demonstrating a robust safety profile, correlation with neurological improvements, and reductions in systemic inflammation following TBI. While still preliminary, evidence suggests cell-based therapies may become a viable treatment for TBI based on their ability to promote neuroregeneration and reduce inflammation.

SUBMITTER: Chrostek MR 

PROVIDER: S-EPMC6826445 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications


Traumatic brain injuries (TBIs) are a leading cause of death and disability. Additionally, growing evidence suggests a link between TBI-induced neuroinflammation and neurodegenerative disorders. Treatments for TBI patients are limited, largely focused on rehabilitation therapy, and ultimately, fail to provide long-term neuroprotective or neurorestorative benefits. Because of the prevalence of TBI and lack of viable treatments, new therapies are needed which can promote neurological recovery. Cel  ...[more]

Similar Datasets

| S-EPMC8230536 | biostudies-literature
| S-EPMC4356170 | biostudies-literature
| S-EPMC7139349 | biostudies-literature
| S-EPMC6890857 | biostudies-literature
| S-EPMC7578125 | biostudies-literature
| S-EPMC4358068 | biostudies-literature
| S-EPMC4500763 | biostudies-literature
| S-EPMC5517445 | biostudies-other
| S-EPMC5896006 | biostudies-literature
| S-EPMC7067417 | biostudies-literature